Related Experiment Video
Updated: Jul 10, 2026

11:59
Detection of Residual Donor Erythroid Progenitor Cells after Hematopoietic Stem Cell Transplantation for Patients with Hemoglobinopathies
Published on: September 6, 2017
Historical hematology: May-Hegglin anomaly
Hidehiko Saito1, Shinji Kunishima
1Nagoya Central Hospital, Nagoya, Japan. hidehiko.saito@jr-central.co.jp
American Journal of Hematology
|November 3, 2007
Summary
May-Hegglin anomaly is a rare platelet disorder caused by mutations in the MYH9 gene, leading to giant platelets and leukocyte inclusions. Research is exploring how these MYH9 gene mutations cause diverse symptoms.
Area of Science:
- Hematology
- Genetics
Background:
- May-Hegglin anomaly is a rare autosomal dominant platelet disorder.
- Characterized by thrombocytopenia, giant platelets, and leukocyte inclusions.
Discussion:
- Mutations in the nonmuscle myosin heavy chain IIA (MYH9) gene are identified as the cause.
- Inclusion bodies are aggregates of MYH9, found only in granulocytes.
Key Insights:
- MYH9 gene mutations are responsible for May-Hegglin anomaly and related disorders.
- These disorders include Sebastian, Fechtner, and Epstein syndromes, often with additional symptoms like deafness, nephritis, or cataracts.
Outlook:
- Further research is needed to understand why inclusion bodies are absent in platelets, monocytes, and lymphocytes.
- Investigating the mechanisms by which a single MYH9 mutation leads to varied phenotypes is a key area of interest.
Related Concept Videos
Overview of Hematopoiesis
Hematopoiesis, or blood cell production, is a vital biological process that begins early in embryonic development and continues throughout life. This process generates the various types of cells found in blood, including red blood cells, white blood cells, and platelets from hematopoietic stem cells (HSCs).
Developmental Phases of Hematopoiesis
Initially, HSCs are formed in the embryonic yolk sac, a critical site for early blood cell production. These stem cells subsequently migrate to other...
Developmental Phases of Hematopoiesis
Initially, HSCs are formed in the embryonic yolk sac, a critical site for early blood cell production. These stem cells subsequently migrate to other...
Multipotency of Hematopoietic Stem Cells
The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...
Hematopoiesis
The process of blood cell formation is called hematopoiesis. Hematopoiesis starts early during development, on the seventh day of embryogenesis. This phase of hematopoiesis is called the primitive wave, wherein the extraembryonic yolk sac allows the production of erythroid cells and endothelial cells from a common precursor called hemangioblast. The erythroid cells provide oxygen to support the growth of the rapidly dividing embryo. Hemangioblasts later develop into hematopoietic stem cells or...
Blood Transfusion and Agglutination
Blood transfusion is a therapeutic measure to restore the blood volume after extensive blood loss due to an accident or a medical procedure. Blood transfusion involves drawing a certain amount of blood from a suitable donor and infusing it into the recipient.
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
Multiple Allele Traits
The Concept of Multiple Allelism
Disorders of Hemostasis
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
